News
Boston.com / Business / Blue Cross will cover costly drug for asthma
archive.boston.com
9 Oct Federal regulators approved Xolair in June and Dr. Peter Goldbach of Blue Cross said it is the most expensive allergy and asthma drug the ...
John Peter Goldbach - Newspapers.comwww.newspapers.com › ... › › Jan › 24 › Page 20
www.newspapers.com
Clipping found in Pittsburgh Sun-Telegraph in Pittsburgh, Pennsylvania on Jan 24, John Peter Goldbach JohnGoldbach . c f teran tnpoye ...
Blue Cross to require preapproval for scans - The Boston Globe
archive.boston.com
Dr. Peter Goldbach, a medical director at Blue Cross, said costs for high-tech imaging are increasing at an annual rate of about 20 percent. ...
Why and how to offer a successful smoking cessation program |...
www.benefitnews.com
Earlier this year, the Surgeon General issued a new report on smoking and health, marking the 50th anniversary of the agencys landmark study announcing...
sorted by relevance / date